The role of metformin in the modern strategy of treatment and prevention of type 2 diabetes mellitus
https://doi.org/10.14341/2072-0351-5494
Abstract
Metformin is a major antihyperglycemic agent used for the treatment of DM2. Analysis of the mechanism of its action is presented. Cardioprotectiveand anticancer activities of metformin are discussed. Results of multicentre studied of metformin are described.
References
1. Metformin. The Gold Standard. A Scientific Handbook. / Ed. Bailey C.J., Campbell J.W., Chan J.C.N. Wiley. - 2007. - P. 1.
2. Metformin. The Gold Standard. A Scientific Handbook. / Ed. Bailey C.J., Campbell J.W., Chan J.C.N. Wiley. - 2007. - P. 37.
3. Metformin. The Gold Standard. A Scientific Handbook. / Ed. Bailey C.J., Campbell J.W., Chan J.C.N. Wiley. - 2007. - P. 77-88.
4. Muller S., Denet S., Candiloros H. Action of metformin on erythrocyte membrane fluidity in vitro and in vivo // European Jornal of Pharmacology. - 1997. - 337. - Р. 103-110.
5. Jonson A.B., Webster J.M., SUM C.F. The impact of metformin therapy on hepatic glucose production and sceletal muscule glycogen synthase activity in overweight type 2 diabetes patients // Metabolism. - 1993. - 42. - Р. 1217-1222.
6. Tiikkainen M., Hakkinen A.M., Korsheninnikova E., Nyman T. Effect of Rosiglitazone and Metformin on liver fat content, hepatic insulin resistance, insulin clearancew, and gen expression in adipose tissue in patients with type 2 diabetes / Diabetes 2004. - 53. - Р. 2169-2176.
7. Scarpello J.H. Improving survival with metformin: the evidence base to day // Diabetes and Metabolism. - 2003. - 29. - 6S36-6S43.
8. Bailey C.J., Howlett H.C.S. Defining patient populations not indicated for metformin. // Metformin. The Gold Standard. A Scientific Handbook / Ed. Bailey C.J., Campbell J.W., Chan J.C.N. Wiley. - 2007. - P. 193-198.
9. Emsley-Smith A.M., Boyle D.I., Evance J.M., Sullivan F., Morris A.D. Contraindication to metformin therapy in patients with type 2 diabetes - a population-based study of adherence to prescribing quidelines // Diabetic Medicine. - 2003. - 18. - Р. 483-488.
10. Stacpoole P.W., Wright E.C., Baumgarten T.G. Natural history and course of acquired lactic acidosis in adult. DCA-Lactic Acidosis Study Groop // The Am. Jornal of Medicine. - 1992. - 97. - Р. 47-54.
11. Eurich D.T., Majumdar S.R., Mc Alister F.A., Tsuyuki R.T., Johanson J.A. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure // Diabetes care. - 2005. - 28. - Р. 2345- 2351.
12. Mc Donald A., Eurich D.T., Mayumidar S.R. Treatment of type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case-Control Study From UK General Practice Research Datebase // Diabetes Care. - 2010. - 33. - Р. 1210-1219.
13. Bowker S.L., Veugelers P., Majumdar S.R., Jonson J.A. Increased Cancer- Related Mortalitt for Patients With Type 2 Diabetes Who Use Sulfanilureas or Insulin // Diabetes Care. - 2006. - 29. - Р. 254-258.
14. Currie C.J., Pool C.D., Gale E.A.M. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes // Diabetology. DOI: 10. 1007/s00125-009-1440-6.
15. Landman G.W.G., Kleefstra N., Van Haleren K.J.J. Metformin associated with Lower Cancer Mortality in Type 2 Diabetes // Diabetes Care. - 2010. - 33. - Р. 322-326.
16. Бернштейн Л.М. Гиполипидемические и антидиабетические препа- раты как средство предупреждения и терапии злокачественных опу- холей: клинические данные. НИИ онкологии им. проф. Н.Н. Петрова МЗ РФ, Санкт-Петербург // Сборник тезисов VIII Российского онкологического конгресса. - М., 2004. - С. 106-108 .
Review
For citations:
Smirnova O.M. The role of metformin in the modern strategy of treatment and prevention of type 2 diabetes mellitus. Diabetes mellitus. 2010;13(3):83-90. (In Russ.) https://doi.org/10.14341/2072-0351-5494
Views:
150017
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
